These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 34132674)

  • 21. 68Ga-FAPI PET/CT Detected Non-FDG-Avid Gastric Stromal Tumor.
    Qiu L; Lan L; Liu H; Deng J; Chen Y
    Clin Nucl Med; 2022 Mar; 47(3):226-227. PubMed ID: 34392281
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of 68Ga-FAPI and 18F-FDG PET/CT in Dermatofibrosarcoma Protuberans.
    Wu J; Zhang S; Rao Z; Wang Y; Zhang C
    Clin Nucl Med; 2022 Jul; 47(7):629-631. PubMed ID: 35452009
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 68Ga-DOTA-FAPI-04 PET/CT in Neuroendocrine Carcinoma of the Liver With Elevated AFP Level: Comparison With 18F-FDG PET/CT.
    Ergül N; Yılmaz B; Cin M; Çermik TF
    Clin Nucl Med; 2022 Jan; 47(1):e29-e31. PubMed ID: 34284483
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 18F-FDG and 68Ga-FAPI PET/CT in the Evaluation of Ground-Glass Opacity Nodule.
    Chen H; Pang Y; Meng T; Yu X; Sun L
    Clin Nucl Med; 2021 May; 46(5):424-426. PubMed ID: 33782300
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 68Ga-FAPI PET/CT Versus 18F-FDG PET/CT for Detecting Metastatic Lesions in a Case of Radioiodine-Refractory Differentiated Thyroid Cancer.
    Fu H; Fu J; Huang J; Pang Y; Chen H
    Clin Nucl Med; 2021 Nov; 46(11):940-942. PubMed ID: 34034326
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of 68Ga-DOTANOC and 18F-FDG PET-CT Scans in the Evaluation of Primary Tumors and Lymph Node Metastasis in Patients With Rectal Neuroendocrine Tumors.
    Zhou Z; Wang Z; Zhang B; Wu Y; Li G; Wang Z
    Front Endocrinol (Lausanne); 2021; 12():727327. PubMed ID: 34539577
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A Head-to-Head Comparison of 68Ga-LNC1007 and 2-18F-FDG/68Ga-FAPI-02 PET/CT in Patients With Various Cancers.
    Zang J; Lin R; Wen X; Wang C; Zhao T; Jakobsson V; Yang Y; Wu X; Guo Z; Chen X; Zhang J; Miao W
    Clin Nucl Med; 2023 Oct; 48(10):861-868. PubMed ID: 37682601
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of the application of 18F-FDG and 68Ga-DOTATATE PET/CT in neuroendocrine tumors: A retrospective study.
    Hu X; Li D; Wang R; Wang P; Cai J
    Medicine (Baltimore); 2023 May; 102(19):e33726. PubMed ID: 37171344
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MIB-1 Index-Stratified Assessment of Dual-Tracer PET/CT with
    Sampathirao N; Basu S
    J Nucl Med Technol; 2017 Mar; 45(1):34-41. PubMed ID: 28154019
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Use of 68Ga-FAPI PET/CT for Evaluation of Peritoneal Carcinomatosis Before and After Cytoreductive Surgery.
    Zhao L; Pang Y; Wei J; Hao B; Chen H
    Clin Nucl Med; 2021 Jun; 46(6):491-493. PubMed ID: 33782310
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 68Ga-FAPI PET imaging monitors response to combined TGF-βR inhibition and immunotherapy in metastatic colorectal cancer.
    Li K; Liu W; Yu H; Chen J; Tang W; Wang J; Qi M; Sun Y; Xu X; Zhang J; Li X; Guo W; Li X; Song S; Tang S
    J Clin Invest; 2024 Jan; 134(4):. PubMed ID: 38175716
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The potential role of 68Ga-FAPI-04 PET/CT for screening malignancy in suspected colonic lesions.
    Erol Fenercioğlu Ö; Beyhan E; Şahin R; Baloğlu MC; Arslan E; Çermik TF; Ergül N
    Nucl Med Commun; 2023 Oct; 44(10):896-899. PubMed ID: 37450605
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dual-Tracer (68Ga-DOTATOC and 18F-FDG-)-PET/CT Scan and G1-G2 Nonfunctioning Pancreatic Neuroendocrine Tumors: A Single-Center Retrospective Evaluation of 124 Nonmetastatic Resected Cases.
    Paiella S; Landoni L; Tebaldi S; Zuffante M; Salgarello M; Cingarlini S; D'Onofrio M; Parisi A; Deiro G; Manfrin E; Bianchi B; Montagnini G; Crinò SF; Bassi C; Salvia R
    Neuroendocrinology; 2022; 112(2):143-152. PubMed ID: 33508821
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intense FAPI Uptake in Inflammation May Mask the Tumor Activity of Pancreatic Cancer in 68Ga-FAPI PET/CT.
    Luo Y; Pan Q; Zhang W; Li F
    Clin Nucl Med; 2020 Apr; 45(4):310-311. PubMed ID: 31977474
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of [
    Chen H; Pang Y; Wu J; Zhao L; Hao B; Wu J; Wei J; Wu S; Zhao L; Luo Z; Lin X; Xie C; Sun L; Lin Q; Wu H
    Eur J Nucl Med Mol Imaging; 2020 Jul; 47(8):1820-1832. PubMed ID: 32222810
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 68Ga-FAPI and 18F-FDG PET/CT Findings in a Patient With Pancreatic Tuberculosis Mimicking Malignant Tumor.
    Sun R; Huang Z; Wei J; Zeng C; Chen X
    Clin Nucl Med; 2022 Jul; 47(7):653-654. PubMed ID: 35261359
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Integrated PET/MRI With 68Ga-DOTATATE and 18F-FDG in Pheochromocytomas and Paragangliomas: An Initial Study.
    Xu S; Pan Y; Zhou J; Ju H; Zhang Y
    Clin Nucl Med; 2022 Apr; 47(4):299-304. PubMed ID: 35143455
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 18F-FDG Versus 68Ga-FAPI PET/CT in Visualizing Primary Hepatic Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue.
    Pang Y; Zhao L; Shang Q; Meng T; Chen H
    Clin Nucl Med; 2022 Apr; 47(4):375-377. PubMed ID: 34661557
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Metastatic Poorly Differentiated Thyroid Cancer With Heterogeneous Distribution of 18F-FDG, 68Ga-DOTATATE, and 68Ga-PSMA on PET/CT.
    Civan C; Isik EG; Simsek DH
    Clin Nucl Med; 2021 Apr; 46(4):e212-e213. PubMed ID: 33156050
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 68Ga-FAPI PET/CT Versus 18F-FDG PET/CT for the Evaluation of Disease Activity in Takayasu Arteritis.
    Wu S; Pang Y; Zhao L; Zhao L; Chen H
    Clin Nucl Med; 2021 Oct; 46(10):847-849. PubMed ID: 34028415
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.